276 related articles for article (PubMed ID: 10794581)
1. Addiction: part II. Identification and management of the drug-seeking patient.
Longo LP; Parran T; Johnson B; Kinsey W
Am Fam Physician; 2000 Apr; 61(8):2401-8. PubMed ID: 10794581
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. Prescription drug misuse: a growing national problem.
Hertz JA; Knight JR
Adolesc Med Clin; 2006 Oct; 17(3):751-69; abstract xiii. PubMed ID: 17030290
[TBL] [Abstract][Full Text] [Related]
4. Abuse of prescription drugs.
Wilford BB
West J Med; 1990 May; 152(5):609-12. PubMed ID: 2349801
[TBL] [Abstract][Full Text] [Related]
5. Prescribing Schedule 8 drugs.
Bird S
Aust Fam Physician; 2006; 35(1-2):59-60. PubMed ID: 16489388
[TBL] [Abstract][Full Text] [Related]
6. Abuse of prescription drugs and the risk of addiction.
Compton WM; Volkow ND
Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S4-7. PubMed ID: 16563663
[TBL] [Abstract][Full Text] [Related]
7. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
[TBL] [Abstract][Full Text] [Related]
8. A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache.
Schuckman H; Hazelett S; Powell C; Steer S
Subst Use Misuse; 2008; 43(5):589-95. PubMed ID: 18393078
[TBL] [Abstract][Full Text] [Related]
9. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.
Michna E; Ross EL; Hynes WL; Nedeljkovic SS; Soumekh S; Janfaza D; Palombi D; Jamison RN
J Pain Symptom Manage; 2004 Sep; 28(3):250-8. PubMed ID: 15336337
[TBL] [Abstract][Full Text] [Related]
10. National drug control policy and prescription drug abuse: facts and fallacies.
Manchikanti L
Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
[TBL] [Abstract][Full Text] [Related]
11. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
[TBL] [Abstract][Full Text] [Related]
12. Non-medical use and abuse of commonly prescribed medications.
Riggs P
Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
[TBL] [Abstract][Full Text] [Related]
13. Does adherence monitoring reduce controlled substance abuse in chronic pain patients?
Manchikanti L; Manchukonda R; Damron KS; Brandon D; McManus CD; Cash K
Pain Physician; 2006 Jan; 9(1):57-60. PubMed ID: 16700282
[TBL] [Abstract][Full Text] [Related]
14. [Prescription shopping of addictive drugs in Norway].
Winther RB; Bramness JG
Tidsskr Nor Laegeforen; 2009 Mar; 129(6):517-20. PubMed ID: 19282887
[TBL] [Abstract][Full Text] [Related]
15. Adolescent substance use and abuse: recognition and management.
Griswold KS; Aronoff H; Kernan JB; Kahn LS
Am Fam Physician; 2008 Feb; 77(3):331-6. PubMed ID: 18297958
[TBL] [Abstract][Full Text] [Related]
16. Documenting and improving opioid treatment: the Prescription Opioid Documentation and Surveillance (PODS) System.
Wilsey BL; Fishman SM; Casamalhuapa C; Gupta A
Pain Med; 2009; 10(5):866-77. PubMed ID: 19594846
[TBL] [Abstract][Full Text] [Related]
17. Substance abuse concerns in the treatment of pain.
Vourakis C
Nurs Clin North Am; 1998 Mar; 33(1):47-60. PubMed ID: 9478905
[TBL] [Abstract][Full Text] [Related]
18. Abuse of benzodiazepines: the problems and the solutions. A report of a Committee of the Institute for Behavior and Health, Inc.
Am J Drug Alcohol Abuse; 1988; 14 Suppl 1():1-69. PubMed ID: 2902782
[TBL] [Abstract][Full Text] [Related]
19. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder.
Bukstein O
Adolesc Med State Art Rev; 2008 Aug; 19(2):242-53, viii. PubMed ID: 18822830
[TBL] [Abstract][Full Text] [Related]
20. The Minnesota Prescription Monitoring Program.
Herman C
Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
